openPR Logo
Press release

Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 2021

06-09-2017 12:25 PM CET | Health & Medicine

Press release from: zion market research

Generic Drug Market: Global Generic Drug Share to Reach USD

Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by 2021, growing at a CAGR of around 10.8 % between 2016 and 2021.

Pharmacology is the study of drugs and medicines, including their uses, effects, and characteristic. Generic drugs are chemically identical to their branded counterparts. Although generic drugs are bioequivalent to branded drugs, they are sold at the significant discount from branded drugs prices. As per the FDA approval, the generic drug should contain the same active ingredient as their branded counterpart; it should be bioequivalent and should meet batch requirements for identity, quality, purity, and strength. It should be identical on the route of administration and dosage form. It should be manufactured under the same rules and regulation of FDA’s good manufacturing practice required for branded drugs. Generic drugs manufacturing companies are capable of selling generic drugs at the lower price because they are not required to repeat costly clinical trials and pay for marketing and promotion strategies.

Request Free Sample copy of Research Report @ https://www.zionmarketresearch.com/sample/generic-drug-market

Globally, the market for the generic drug has been propelled by new government initiatives to produce generic drugs and mainly to promote the use of generic drugs against chronic diseases. Patent expiration of branded drugs is one of the key influencers for the growth and prime reason for generating more revenue for generic drugs market. Moreover, new emerging markets of developing countries and low cost of generic drugs are majorly responsible for thickening the growth of generic drugs market. In spite of this, the market is affected by high competition within the globe and it is due to, economic expenditure required for the production of generic drugs is the very low thus a number of leading companies taking interest in the production of generic drugs. In future, new developing and uncovered markets may responsible for the generation of new opportunities.

The market for the generic drug has been segmented on the basis of the brand as pure generic drug and branded generic drugs. Branded generic drugs are marketed under another company’s brand name but they are bioequivalent to their generic counterparts. Due to high involvement of companies in manufacturing pure generic drugs, pure generic drug segment is dominating the market.

Browse the full "Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at https://www.zionmarketresearch.com/report/generic-drug-market

Based on the therapeutic application the market of generic drugs has been segmented as central nervous system (CNS), cardiovascular, dermatology, oncology, respiratory and others. With more than 20% revenue contribution, the cardiovascular segment was leading the generic drug market in 2015 due to a number of patent expiry of cardiovascular drugs. With more than 15 % revenue contribution, central nervous system (CNS) will show significant growth over the forecast period.

The market for the generic drug has been segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. North America is dominating the generic drug market due to high demand and increasing the prevalence of chronic diseases. Asia-Pacific is expected to show good growth in the forecast period. In Asia Pacific, India and China are leading countries in the generic drug market.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/generic-drug-market

Key operating players for the generic drugs market are Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Abbott Healthcare Pvt. Ltd., Actavis Pharmaceuticals and Sun Pharmaceuticals.

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
4283, Express Lane,
Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: http://www.zionmarketresearch.com
Blog: https://zionmarketresearch.wordpress.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 2021 here

News-ID: 572074 • Views:

More Releases from zion market research

Pediatric Clinical Trials Market: Advancing Child Health Through Purpose-Built Research
Pediatric Clinical Trials Market: Advancing Child Health Through Purpose-Built R …
The global pediatric clinical trials market is entering a decade of steady expansion as regulators, industry sponsors, and patient advocates work to close long-standing evidence gaps in medicines for children. Valued at roughly USD 19.85 billion in 2024, the market is projected to climb to about USD 32.96 billion by 2034, reflecting a 5.20% CAGR (2025-2034). Growth is being shaped by policy incentives, innovation in trial design, and a widening
PFAS Filtration Market Set to Nearly Double by 2034 Amid Rising Environmental and Health Concerns
PFAS Filtration Market Set to Nearly Double by 2034 Amid Rising Environmental an …
The global PFAS filtration market is poised for robust growth over the next decade, reflecting increased environmental awareness, stricter regulations, and technological advancements in water purification systems. Valued at approximately USD 2.00 billion in 2024, the market is expected to reach around USD 3.97 billion by 2034, registering a compound annual growth rate (CAGR) of 7.10% between 2025 and 2034. Access key findings and insights from our Report in this sample
Zinc Battery Market to Reach USD 3.67 Billion by 2034 Amid Rising Demand for Sustainable Energy Storage
Zinc Battery Market to Reach USD 3.67 Billion by 2034 Amid Rising Demand for Sus …
The global zinc battery market was valued at approximately USD 1.02 billion in 2024 and is projected to grow significantly to around USD 3.67 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.60% between 2025 and 2034. This dynamic growth reflects the rising global emphasis on low-cost, safe, and eco-friendly energy storage alternatives to lithium-ion batteries. Access key findings and insights from our Report in this sample
Aircraft Interior Decoration Materials Market to Reach USD 57.40 Billion by 2034
Aircraft Interior Decoration Materials Market to Reach USD 57.40 Billion by 2034
The global aircraft interior decoration materials market was valued at approximately USD 26.59 billion in 2024 and is projected to grow to USD 57.40 billion by 2034, exhibiting a robust compound annual growth rate (CAGR) of 8.00% from 2025 to 2034. This impressive growth is fueled by the rising demand for passenger comfort, aesthetics, and personalized cabin experiences, as well as the continued expansion of the aviation industry worldwide. Access key

All 5 Releases


More Releases for Generic

Top 10 Generic Drugs Companies Analysis (2024)
Expansion of Biosimilar Development: The increasing acceptance of biosimilars offers opportunities for pharmaceutical companies to develop and market affordable alternatives to expensive biologic treatments. Get more Details with Sample PDF Copy@https://www.theinsightpartners.com/sample/TIPRE00003414/?utm_source=OpenPR&utm_medium=10734 Major Companies operating in the Generic Drugs Market are: 1. Teva Pharmaceutical Industries Ltd. 2. Mylan N.V. 3. Dr. Reddy's Laboratories Ltd. 4. Novartis Pharmaceuticals Corporation 5. Apotex Inc. 6. Pfizer Inc. 7. Endo Pharmaceuticals Inc. 8. Fresenius Kabi AG 9. Lupin Pharmaceuticals, Inc. 10. Cipla Inc. Contact Us: If you have any
Generic Drugs Companies Revenue Analysis 2024-2031
Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007429?utm_source=OpenPR&utm_medium=10379 The Generic Drugs Market is expected to register a CAGR of 7.9% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. The List of Companies 1. Teva Pharmaceutical Industries Ltd. 2. Mylan N.V. 3. Dr. Reddy's Laboratories Ltd. 4. Novartis Pharmaceuticals Corporation 5. Apotex Inc. 6. Pfizer Inc. 7. Endo Pharmaceuticals Inc. 8. Fresenius Kabi AG 9. Lupin Pharmaceuticals, Inc. 10. Cipla Inc. About US The
Global Dolutegravir And Dolutegravir Generic Drugs Market Size by Application, T …
USA, New Jersey- According to Market Research Intellect, the global Dolutegravir And Dolutegravir Generic Drugs market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The market for dolutegravir and its generic medications is expanding significantly as a result of rising HIV infection rates worldwide and rising
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth? The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,
Top 10 Generic Drugs Companies Analysis (2024)
Expansion of Biosimilar Development: The increasing acceptance of biosimilars offers opportunities for pharmaceutical companies to develop and market affordable alternatives to expensive biologic treatments. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00003414/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Generic Drugs Market are: • Teva Pharmaceutical Industries Ltd. • Mylan N.V. • Dr. Reddy's Laboratories Ltd. • Novartis Pharmaceuticals Corporation • Apotex Inc. • Pfizer Inc. • Endo Pharmaceuticals Inc. • Fresenius Kabi AG • Lupin Pharmaceuticals, Inc. • Cipla Inc. Contact Us: If you have any queries about this report or if you would
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall. Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to